Soluble immune checkpoints CD27, Lag3, PD-L2 and Tim3 in early stage NSCLC patients. (March 2018) - Gamerith, G.; Hackl, H.; Wallinger, P.; Fandel, L.; Kern, J.; Augustin, F.; Lorenz, E.; Hoflehner, E.; Mildner, F.; Moser, P.; Sprung, S.; Zelger, B.; et al.